(Q33503391)

27 July 2017

Cladribine for untreated or early low-grade non-Hodgkin's lymphoma (English)

1 reference

27 July 2017

J Liliemark

1

1 reference

27 July 2017

U Martinsson

2

1 reference

27 July 2017

E Cavallin-Ståhl

3

1 reference

27 July 2017

E Svedmyr

4

1 reference

27 July 2017

A Porwit

5

1 reference

27 July 2017

M Strömberg

6

1 reference

27 July 2017

G Juliusson

7

1 reference

27 July 2017

1 August 1998

1 reference

27 July 2017

1 reference

27 July 2017

30

1 reference

27 July 2017

573-581

1 reference

27 July 2017

5-6

1 reference

Antileukemic and immunosuppressive activity of 2-chloro-2'-deoxyadenosine

27 July 2017

1 reference

https://api.crossref.org/works/10.3109%2F10428199809057569

Cladribine in treatment of chronic progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809057569

2-Chlorodeoxyadenosine Treatment of Refractory Chronic Lymphocytic Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809057569

Intermittent infusion of cladribine (CdA) in previously treated patients with low-grade non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809057569

High response rates with short infusional 2-chlorodeoxyadenosine in de novo and relapsed low-grade lymphoma. Australian and New Zealand Lymphoma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809057569

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809057569

2-chlorodeoxyadenosine (2-CDA) therapy in previously untreated patients with follicular stage III-IV non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809057569

10.3109/10428199809057569

21 January 2018

Identifiers

DOI

1 reference

27 July 2017

1 reference